Polpharma S.A.

Polpharma actively operates in the markets of Central and Eastern Europe, the Caucasus and Central Asia. For over 80 years, Polpharma have been trusted by patients, healthcare professionals and business partners alike. Polpharma is among the top 20 generic drug manufacturers in the world. In Polpharma Group and associated company employs more than 7,500 people in Poland and on international markets. Polpharma owns 7 manufacturing plants in Poland, Russia and Kazakhstan, and 7 research and development centers. Polpharma Group’s portfolio includes about 600 products, and another 200 are being developed. Polpharma manufactures a wide range of prescription drugs and pharmaceuticals for in-patient care. Polpharma has a leading share in the key therapeutic areas in Poland. The company specializes in pharmaceutical preparations used in cardiology, gastroenterology and neurology. Over the counter medications (OTC) account for a significant part of company product portfolio. In addition,  portfolio comprises dietary supplements, medical devices, cosmetic products and phyto-pharmaceuticals. Polpharma is also one of the largest Polish manufacturers of active pharmaceutical ingredients (APIs), which competes successfully in the developed markets of the EU and the US. Polpharma owns a wide range of prizes and renowned certificates, among them Ethical Company, Pomeranian Digital Finance Award, Employer of the 2018, Top Brand 2017, etc.
We are glad and proud to cooperate with Polpharma Group in Azerbaijan market.